Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. (Q35096654)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

title

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Víctor Jiménez-Yuste

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Fernando Hernandez-Navarro

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ana Villar

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

21-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670328%20AND%20SRC:MED&resulttype=core&format=json

Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired hemophilia due to factor VIII inhibitors in 34 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired haemophilia in South Australia: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

A Randomized Study of Factor VIII or Prothrombin Complex Concentrate Infusions in Children with Haemophilia and Antibodies to Factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired haemophilia in the elderly is a severe disease: report of five new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired haemophilia: experiences with a standardized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Porcine factor VIII: current status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Prednisone and low-dose activated prothrombin complex concentrates for FVIII inhibitor in nonhaemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired haemophilia in association with organ-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Management of haemophilia in patients with high-titre inhibitors: focus on the evolution of activated prothrombin complex concentrate AUTOPLEX T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Autoimmune factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Treatment of haemophilia in the United Kingdom 1981-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

The use of agents that by-pass factor VIII inhibitors in patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired haemophilia - a study of ten cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Successful Treatment of Acquired Hemophilia with Oral Immunosuppressive Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Postpartum acquired hemophilia (factor VIII inhibitors): a case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired factor VIII inhibitors in nonhemophilic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Postpartum acquired factor VIII inhibitors: results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Successful treatment of a non-haemophilic patient with inhibitor to factor VIII by double-filtration plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Factor Xa and prothrombin: mechanism of action of FEIBA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

Disappearance of factor VIII autoantibodies preceding autoimmune haemolytic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X

A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04162.X